Emphysematous pyelonephritis - Revision history

Rossdonaldson1: /* Evaluation */

2022-01-06T07:11:53Z

Evaluation

← Older revision		Revision as of 07:11, 6 January 2022
Line 21:		Line 21:

	==Evaluation==		==Evaluation==
			[[File:PMC4421217 sfn002fig2.png\|thumb\|Axial CT scan image of left kidney reveals emphysematous pyelonephritis.]]
	===Labs===		===Labs===
	*CBC with [[leukocytosis\|high WBC]], [[thrombocytopenia\|low platelets]]		*CBC with [[leukocytosis\|high WBC]], [[thrombocytopenia\|low platelets]]

Rossdonaldson1: /* Background */

2020-05-02T10:42:59Z

Background

← Older revision		Revision as of 10:42, 2 May 2020
Line 1:		Line 1:
	==Background==		==Background==
			[[File:Blausen 0592 KidneyAnatomy 01.png\|thumb\|Renal anatomy.]]
	*Rare gas-forming infection nearly always occurring in patients with [[DM]] and obstruction		*Rare gas-forming infection nearly always occurring in patients with [[DM]] and obstruction
	**Patients appear toxic and [[septic]]; nephrectomy may be required		**Patients appear toxic and [[septic]]; nephrectomy may be required

Rossdonaldson1 at 10:33, 2 May 2020

2020-05-02T10:33:12Z

← Older revision		Revision as of 10:33, 2 May 2020
Line 2:		Line 2:
	*Rare gas-forming infection nearly always occurring in patients with [[DM]] and obstruction		*Rare gas-forming infection nearly always occurring in patients with [[DM]] and obstruction
	**Patients appear toxic and [[septic]]; nephrectomy may be required		**Patients appear toxic and [[septic]]; nephrectomy may be required

			{{UTI types}}

	==Clinical Features<ref> Tang HJ, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001 Jun. 34(2):125-30. </ref>==		==Clinical Features<ref> Tang HJ, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001 Jun. 34(2):125-30. </ref>==

ClaireLewis at 16:40, 16 October 2019

2019-10-16T16:40:02Z

← Older revision		Revision as of 16:40, 16 October 2019
Line 9:		Line 9:
	*[[Nausea/vomiting]]		*[[Nausea/vomiting]]
	*[[Dyspnea]]		*[[Dyspnea]]
	*Renal dysfunction		*[[AKI\|Renal dysfunction]]
	*[[Altered mental status]]		*[[Altered mental status]]
	*[[Shock]]		*[[Shock]]
Line 19:		Line 19:
	==Evaluation==		==Evaluation==
	===Labs===		===Labs===
	*CBC with high WBC, low platelets		*CBC with [[leukocytosis\|high WBC]], [[thrombocytopenia\|low platelets]]
	*[[Urinalysis]] with urine culture		*[[Urinalysis]] with urine culture
	*Creatinine		*Creatinine
Line 34:		Line 34:

	==Management==		==Management==
	*IVF		*[[IVF]]
	*Antibiotics		*Antibiotics
	**IV ampicillin, gentamicin, metronidazole		**IV [[ampicillin]], [[gentamicin]], [[metronidazole]]
	**[[Vancomycin]] in place of [[ampicillin]] for penicillin allergy		**[[Vancomycin]] in place of [[ampicillin]] for penicillin allergy

Line 58:		Line 58:
	[[Category:Renal]]		[[Category:Renal]]
	[[Category:Urology]]		[[Category:Urology]]
			[[Category:ID]]

Rossdonaldson1: Text replacement - "b/l" to "bilateral"

2017-12-18T03:05:01Z

Text replacement - "b/l" to "bilateral"

← Older revision		Revision as of 03:05, 18 December 2017
Line 31:		Line 31:
	**Class 3A - perinephric extension of gas or abscess		**Class 3A - perinephric extension of gas or abscess
	**Class 3B - extension of gas beyond Gerota fascia		**Class 3B - extension of gas beyond Gerota fascia
	**Class 4 - ~~b/l~~ or EPN in solitary kidney		**Class 4 - bilateral or EPN in solitary kidney

	==Management==		==Management==

Ostermayer: Text replacement - "Vancomycin " to "Vancomycin "

2017-01-27T20:39:37Z

Text replacement - "Vancomycin " to "Vancomycin "

← Older revision		Revision as of 20:39, 27 January 2017
Line 37:		Line 37:
	*Antibiotics		*Antibiotics
	**IV ampicillin, gentamicin, metronidazole		**IV ampicillin, gentamicin, metronidazole
	**Vancomycin in place of [[ampicillin]] for penicillin allergy		**[[Vancomycin]] in place of [[ampicillin]] for penicillin allergy

	==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==		==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==

Rossdonaldson1: Text replacement - "UA" to "Urinalysis"

2016-10-02T14:45:31Z

Text replacement - "*UA" to "*Urinalysis"

← Older revision		Revision as of 14:45, 2 October 2016
Line 20:		Line 20:
	===Labs===		===Labs===
	*CBC with high WBC, low platelets		*CBC with high WBC, low platelets
	*UA with urine culture		*[[Urinalysis]] with urine culture
	*Creatinine		*Creatinine
	*Blood culture		*Blood culture

Rossdonaldson1: Text replacement - "pcn " to "penicillin "

2016-09-08T13:26:48Z

Text replacement - "pcn " to "penicillin "

← Older revision		Revision as of 13:26, 8 September 2016
Line 37:		Line 37:
	*Antibiotics		*Antibiotics
	**IV ampicillin, gentamicin, metronidazole		**IV ampicillin, gentamicin, metronidazole
	**Vancomycin in place of [[ampicillin]] for ~~pcn~~ allergy		**Vancomycin in place of [[ampicillin]] for penicillin allergy

	==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==		==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==

Rossdonaldson1: Text replacement - " ampicillin " to " ampicillin "

2016-09-08T10:05:37Z

Text replacement - " ampicillin " to " ampicillin "

← Older revision		Revision as of 10:05, 8 September 2016
Line 37:		Line 37:
	*Antibiotics		*Antibiotics
	**IV ampicillin, gentamicin, metronidazole		**IV ampicillin, gentamicin, metronidazole
	**Vancomycin in place of ampicillin for pcn allergy		**Vancomycin in place of [[ampicillin]] for pcn allergy

	==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==		==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==

Neil.m.young: Text replacement - "Cr " to "Creatinine "

2016-08-11T06:29:57Z

Text replacement - "Cr " to "Creatinine "

← Older revision		Revision as of 06:29, 11 August 2016
Line 41:		Line 41:
	==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==		==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==
	*Poor prognostic risk factors:		*Poor prognostic risk factors:
	**Cr > 1.4mg/dL		**Creatinine > 1.4mg/dL
	**Platelets < 60k		**Platelets < 60k
	**Altered mental status		**Altered mental status